UCLA Neuromodulation

05/23/2024

Did you know? TMS can be used off-label to treat both depression and chronic pain, particularly neuropathy and fibromyalgia.

For more information, please visit our website linked in bio.

Source: Bair et. al., 2003

05/20/2024

Every mind deserves care and compassion. 🧠💫 We believe in prioritizing your wellbeing and we’re here to support your mental health journey with TMS therapy. 🩵

—

03/23/2023

Our services are now available to the Pasadena community at our new clinic located at 630 S. Raymond Ave, Suite 336, Pasadena, CA 91105. If you are curious about UCLA TMS, please join us at our open house on April 6th from 4 to 6:30 PM to learn from our expert psychiatrists and get in-person demonstrations of our cutting-edge technology!

———
RSVP Link in Bio
———

Transcranial Magnetic Stimulation (TMS) is a revolutionary new treatment for depression, chronic pain, and other difficult-to-treat illnesses involving the mind and brain. UCLA TMS is the premier provider of TMS for patients in Los Angeles County. We are pleased to announce the expansion of our services to a new clinic in Pasadena to better serve patients throughout the San Gabriel Valley and surrounding communities.

TMS is a safe, non-invasive treatment that applies gentle magnetic pulses to specific areas of the brain. By delivering energy to mood-regulating regions, TMS resets brain networks and helps patients recover from depression. Approximately two-thirds of patients of our patients receive substantial relief from their depression after TMS. Different approaches to TMS also can help relieve chronic pain, OCD, tinnitus, and other conditions.

09/16/2022

If you are currently living with Major Depressive Disorder and seeking help, you may qualify for a research study to evaluate a new treatment for alleviating Major Depressive Disorder (MDD) symptoms that is self-administered with an investigational medical device.

You may be eligible to participate if you are:
· Between 18-70 years old
· Currently diagnosed with Major Depressive Disorder (MDD)

Participants will be asked to use an at-home treatment device daily over the course of 16 weeks and complete questionnaires about their mental health and well-being. Compensation for your participation and parking is provided for in-person research visits.
If you choose to contact us by email, please do not include any sensitive information in your email because the confidentiality of emails cannot be guaranteed. This study is sponsored by the Neurolief, inc.

Local Site Principal Investigator – Andrew F. Leuchter, MD

Contact – nvincecruz@mednet.ucla.edu OR (310) 825-4781

08/04/2022

If you are currently living with Major Depressive Disorder and seeking help, you may qualify for a research study to evaluate a new treatment for alleviating Major Depressive Disorder (MDD) symptoms that is self-administered with an investigational medical device.

You may be eligible to participate if you are:

· Between 18-70 years old

· Currently diagnosed with Major Depressive Disorder (MDD)

Participants will be asked to use an at-home treatment device daily over the course of 16 weeks and complete questionnaires about their mental health and well-being. Compensation for your participation and parking is provided for in-person research visits.

If you choose to contact us by email, please do not include any sensitive information in your email because the confidentiality of emails cannot be guaranteed. This study is sponsored by the Neurolief, inc.

Local Site Principal Investigator – Andrew F. Leuchter, MD

Contact – nvincecruz@mednet.ucla.edu OR (310) 825-4781

08/28/2020

Curious about TMS? Check out some of our flyers to get some additional information! (Available in Spanish and Chinese)

08/12/2020

Welcome to UCLA TMS!

TMS was FDA approved for depression in 2008 and a new, shorter treatment called “theta burst stimulation” requiring as little as 3 minutes per treatment was FDA approved in 2018. A typical treatment course involves daily treatments, Monday through Friday, for six weeks. Treatment is often covered by insurance, and provides 50-60% of people with a meaningful reduction in their symptoms.

For more information, visit our website TMS.ucla.edu

06/17/2020

06/01/2020

Meet Our Provider’s Monday:

Meet Dr. Andrew (Andy) Leuchter, an internationally recognized expert on the treatment of mood disorders. He is the director of the UCLA Transcranial Magnetic Stimulation (TMS) Clinical and Research Service in the Division.
Dr. Leuchter’s research focuses on the enhancement of treatment outcomes in depression, and has focused in treatment resistant depression for two decades, in addition to treating hundreds of patients diagnosed with MDD, OCD, and tinnitus.

Want to learn more about our services at TMS? Check out our website at http://tms.ucla.edu/

05/12/2020

Curious about TMS? Take a look at our website for some more info!